BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6376558)

  • 1. Immunopathology of vitiligo vulgaris, Sutton's leukoderma and melanoma-associated vitiligo in relation to steroid effects. I. Circulating antibodies for cultured melanoma cells.
    Takei M; Mishima Y; Uda H
    J Cutan Pathol; 1984 Apr; 11(2):107-13. PubMed ID: 6376558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of vitiligo vulgaris, Sutton's leukoderma and melanoma-associated vitiligo in relation to steroid effects. II. The IgG and C3 deposits in the skin.
    Uda H; Takei M; Mishima Y
    J Cutan Pathol; 1984 Apr; 11(2):114-24. PubMed ID: 6376559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism.
    Merimsky O; Shoenfeld Y; Yecheskel G; Chaitchik S; Azizi E; Fishman P
    Cancer Immunol Immunother; 1994 Jun; 38(6):411-6. PubMed ID: 8205563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spontaneous regression and leukoderma in malignant melanoma].
    Happle R; Schotola I; Macher E
    Hautarzt; 1975 Mar; 26(3):120-3. PubMed ID: 1126845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halo dermatitis followed by the development of vitiligo associated with Sutton's nevi.
    Brandt O; Christophers E; Fölster-Holst R
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S101-4. PubMed ID: 15858503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Western blot analysis of serum antibody reactivity with human melanoma cell antigens in alopecia areata and vitiligo.
    Galbraith GM; Miller D; Emerson DL
    Clin Immunol Immunopathol; 1988 Sep; 48(3):317-24. PubMed ID: 3042212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum anti-tumour antibodies and auto-antibodies in vitiligo.
    Woolfson H; Finn OA; Mackie RM; McQueen A; MacSween RN
    Br J Dermatol; 1975 Apr; 92(4):395-400. PubMed ID: 1156553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma-associated hypopigmentation: where are the antibodies?
    Merimsky O; Shoenfeld Y; Baharav E; Altomonte M; Chaitchik S; Maio M; Ferrone S; Fishman P
    Am J Clin Oncol; 1996 Dec; 19(6):613-8. PubMed ID: 8931683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital and non-congenital depigmentation.
    Mishima Y
    Mod Probl Paediatr; 1976 Oct 20-23; 20():18-37. PubMed ID: 1032519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune aspects of vitiligo.
    Kemp EH; Waterman EA; Weetman AP
    Autoimmunity; 2001; 34(1):65-77. PubMed ID: 11681494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma and Vitiligo: In Good Company.
    Failla CM; Carbone ML; Fortes C; Pagnanelli G; D'Atri S
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to normal human melanocytes in vitiligo.
    Naughton GK; Eisinger M; Bystryn JC
    J Exp Med; 1983 Jul; 158(1):246-51. PubMed ID: 6345714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of antibodies to human melanoma cell in vitiligo by western blot analysis.
    Hann SK; Kim JB
    Yonsei Med J; 1995 Nov; 36(5):457-61. PubMed ID: 8546004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of topical fluocinonide ointment on phototherapy of psoriasis.
    LeVine MJ; Parrish JA
    J Invest Dermatol; 1982 Feb; 78(2):157-9. PubMed ID: 7057051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitiligo and malignant melanoma: a significant association?
    Gregor RT
    S Afr Med J; 1976 Aug; 50(3F):1447-9. PubMed ID: 973163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
    Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
    Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant melanoma, leukoderma and vitiligo].
    Kraus L; Landthaler M
    Z Hautkr; 1980 Feb; 55(4):218-31. PubMed ID: 6996365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 0.25% desoxymethasone ointment with 0.05% fluocinonide ointment in psoriasis.
    Kuokkanen K
    Curr Med Res Opin; 1976-1977; 4(10):703-5. PubMed ID: 800971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
    Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
    Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Humoral and cellular autoimmunity in genuine vitiligo studied by means of an antigen produced from melanoma cells].
    Höfs T
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):244-50. PubMed ID: 6179826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.